PBLSParabilis Medicines, Inc.
$28.07
$28.07
$25.0152 weeks$41.68
The financials
Parabilis Medicines, Inc. by the numbers
Parabilis Medicines, Inc. (PBLS) reported revenue of $148K in Q2-Q3 2026 (quarter ended Jun 30, 2026). That came with net loss of $98M.
| Income statement | Q2-Q3 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $148K | $0 | n/a |
| Operating income | −$98M | −$40M | n/a |
| Net income | −$98M | −$38M | n/a |
| Diluted EPS | −$8.86 | −$23.85 | n/a |
Biotechnology
The closest names by size in the same industry